Shiga-toxin (Stx) is the cardinal virulence factor of enterohemorrhagic Escherichia coli (EHEC). The genes encoding Stx are carried by a lambdoid phage integrated in the bacterial genome and are fully expressed after a bacterial SOS response induced by DNAdamaging agents. Because nitric oxide (NO) is an essential mediator of the innate immune response of infected colonic mucosa, we aimed to determine its role in Stx production by EHEC. Here we demonstrate that chemical or cellular sources of NO inhibit spontaneous and mitomycin C-induced stx mRNA expression and Stx synthesis, without altering EHEC viability. The synthesis of stx phage is also reduced by NO. This inhibitory effect apparently occurs through the NO-mediated sensitization of EHEC because mutation of the NO sensor nitrite-sensitive repressor results in loss of NO inhibiting activity on stx expression. Thus our findings identify NO as an inhibitor of stx expressing-phage propagation and Stx release and thus as a potential protective factor limiting the development of hemolytic syndromes.
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bacterial infection ͉ mucosal immunology E nterohemorrhagic Escherichia coli (EHEC) are pathogens carried by healthy rearing animals. After infection through the ingestion of contaminated food, EHEC colonize the large intestine and cause gastrointestinal diseases ranging from uncomplicated diarrhea to hemorrhagic colitis. Life-threatening complications, such as hemolytic-uremic syndrome (HUS), develop in Ϸ5-10% of EHEC-infected patients. HUS is defined by a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure, which can yield to a chronic renal failure and even death (1) (2) (3) . O157:H7 is the main EHEC serotype implicated in HUS in Europe and North America (3) . The few recent large outbreaks (4, 5) underline that prevention of primary infection in human remains an elusive goal. Therefore, understanding host-EHEC interactions remains a critical issue in fighting bacterial infection and HUS development.
The main EHEC virulence factor associated with severe human diseases is the Shiga toxin (Stx). Both Stx1 and Stx2 are heteropolymers constituted by a catalytic A subunit and five B subunits implicated in the binding to the receptor glycolipid globotriaosylceramide-3 of endothelial cells. Internalized Stx alters ribosomal function and induces the death of vascular cells (1, 3) . Stx1 and Stx2 are encoded by two type lysogenic phages integrated in the bacterial genome (6) . In a lysogen, the expression of the phage operons is controlled by the protein CI. As a result of EHEC exposure to DNA-damaging agents such as mitomycin C (7) or H 2 O 2 (8) , RecA, which is part of the so-called SOS response, is activated by single-strand DNA and promotes the autocleavage of CI (9) . Then, a regulatory cascade yields to the respective expression of the genes encoding the antiterminators N and Q, Stx, and proteins of phage morphogenesis and lysis (9) (10) (11) (12) (13) . Bacteria are lysed and release Stx and free phage particles in the medium.
An important hallmark of EHEC pathogenesis is the intestinal colonization resulting in attaching and effacing lesions and in induction of a strong mucosal innate immune response. Clinical studies have thus highlighted the strong levels of circulating chemokines and type 1 cytokines in HUS patients (14, 15) . Other effectors of the nonspecific defense program can be produced by the inflamed mucosa, including nitric oxide (NO), a free radical that possesses numerous physiological properties notably in the immune system. Cellular production of NO requires the enzyme NO synthase that oxidizes L-arginine as a substrate; the calciumindependent inducible NO synthase (iNOS) isoform is expressed in numerous cells, e.g., enterocytes, in response to type 1 cytokines (16) . High output of iNOS-derived NO is cytotoxic for pathogenic bacteria (17) or may induce transcriptomic changes (18) (19) (20) (21) by interacting with different NO sensors such as the nitrite-sensitive repressor (NsrR), a key regulator of the nitrosative stress in enterobacteria (22, 23) . NsrR DNA-binding activity is suppressed by NO, yielding to the expression of various genes involved in NO detoxification.
We now show that NO donors-derived NO signals in EHEC through NsrR to inhibit stx2 mRNA expression, Stx2 synthesis, and stx2-phage release. Moreover, in the presence of NO, the expression of recA is down-regulated in mitomycin C-treated EHEC, providing a first line of evidence that NO suppresses the bacterial SOS response induced by DNA-damaging agents. In addition, we demonstrate that NO-producing cells inhibit stx2 gene expression in EHEC/activated human epithelial cells cocultures. Switching the concept that NO is an inducer of the bacterial SOS response, we suggest that NO sensitizes and protects EHEC from DNA damages, thus inhibiting Stx synthesis.
Results
Effect of NO on EHEC Growth and Survival. To establish whether NO affects the growth of the strain EDL933, we treated bacterial suspensions with the NO donor NOR-4 (200 M), in the presence or absence of mitomycin C (200 ng/ml). NO was consistently generated in the bacteria culture medium during the first 12 h and then reached a plateau (Fig. 1a) . The growth of the strain EDL933 was not affected by NO during the early and late growth phases (Fig. 1b) . A dramatic decrease of EHEC growth was observed when bacteria were treated with mitomycin C; this loss of survival was completely inhibited when using NOR-4 (Fig. 1b) .
18 h and after (Fig. 2a) ; this increase was completely inhibited when 200 M NOR-4 were added to the EDL933 cultures (Fig.  2a) . Similarly, Stx2 synthesis was inhibited by Ϸ4.5-fold at 18 and 24 h when NOR-4 was used (Fig. 2b) . The use of the NO scavengers cPTIO in NOR-4-treated EHEC cultures restored stx2 gene expression (Fig. 2a) and Stx2 generation (Fig. 2b) .
To further assess the ability of NO to prevent Stx2 synthesis by EHEC, we stimulated bacteria with mitomycin C in the presence or absence of NOR-4. Addition of mitomycin C to the EDL933 cultures resulted in up-regulation of the stx2 gene (Fig. 3a) and in a large production of Stx2 (Fig. 3b) . When mitomycin Ctreated bacteria were cultured in the presence of 200 M NOR-4, stx2 mRNA expression (Fig. 3a) and Stx2 generation (Fig. 3b) were significantly inhibited by 6.4 Ϯ 1.7-and 2.5 Ϯ 0.9-fold in comparison with EHEC stimulated with mitomycin C, respectively. The expression of the gene stx2 (Fig. 3a) and Stx2 synthesis (Fig. 3b) were partially restored by using cPTIO in the NOR-4-treated EDL933 cultures.
We also found that stx1 was poorly expressed, was not upregulated under mitomycin C treatment, and was not modulated by NOR-4 (data not shown). However, comparable results were obtained with the EHEC strain 86-24, which expresses only the gene stx2 (data not shown).
Experiments performed with NOR-3 gave similar results than those obtained with NOR-4 [supporting information (SI) Fig. 7] ; however, stx2 mRNA expression and Stx2 synthesis by EDL933 were not inhibited by 200 M DEA-NONOate (SI Fig. 7 ), a NO donor that rapidly releases NO ([NO 2 Ϫ ] ϩ [NO 2 Ϫ ] Ϸ200 M, 10 min after the addition of DEA-NONOate). In addition, when NOR-4 was preincubated for 24 h in water before use on bacteria, NO was not further released during the experiments and the inhibitory effect on Stx2 synthesis was not observed (data not shown). Importantly, when NOR-4 and mitomycin C were added together to the bacteria, we did not observe the inhibition of stx2 mRNA expression and of Stx2 synthesis (data not shown); the maximal NO inhibitory effect was observed when mitomycin C was added 6 h after NOR-4.
Finally, to determine whether NO specifically inhibited stx2 mRNA expression we analyzed the expression of the gene fliC encoding the flagellin H7. The expression level of the gene fliC and flagellin synthesis were not modified when the bacteria were treated by NOR-4 (SI Fig. 8 ).
NO-Dependent Decrease of stx2-Phage Release. The gene stx2 of the strain EDL933 is encoded by the phage BP-933W integrated in the bacterial genome. Because NOR-4 inhibits stx2 mRNA expression, we reasoned that NOR-4 may suppress phage production and release by EHEC. The total phage particles were concentrated from culture supernatants of the strain EDL933 exposed or not to mitomycin C and/or NOR-4. After concentration, the presence of phages was visualized by electronic microscopy in each sample (SI Fig. 9 ). We then analyzed by PCR ( Fig. 3c ) and real-time PCR (Fig. 3d ) the presence of the gene stx2 in the viral genome of each sample. The phages harboring the gene stx2 were more present in the supernatant of mitomycin C-treated EHEC when compared with the supernatant of bacteria alone; moreover, this induction under mitomycin C treatment was inhibited by 79.2 Ϯ 5.2% when NOR-4 was added to the bacteria (Fig. 3d) .
NO Down-Regulates recA mRNA Expression. RecA activation is a reliable marker of the SOS response that induces the self cleavage of the phage repressors CI (9) and of the recA gene repressor LexA (24, 25) . To gain further insight in the mechanism by which NO inhibits stx2 mRNA expression, we therefore analyzed the effect of NOR-4 on recA mRNA expression. The expression of the gene was up-regulated by Ϸ9-fold in mitomycin C-treated EHEC in comparison with untreated bacteria; this The strain EDL933 was cultured in LB medium with NOR-4 and/or mitomycin C (Mito.). NOR-4 was added at the beginning of the culture, and mitomycin C was added after 6 h. A 600 nm was determined at indicated times. This figure is the representative data of three independent experiments. ■, EDL933; ᮀ, ϩ NOR-4; F, ϩ mitomycin C; E, ϩ NOR-4 ϩ mitomycin C.
increase was significantly inhibited by 60% in the presence of NOR-4 (Fig. 4) . Additionally, without mitomycin C treatment, recA mRNA expression was decreased by 60.8 Ϯ 1.8% when EDL933 were treated for 18 h with NOR-4 (P Ͻ 0.01; n ϭ 4 experiments).
NsrR Is Implicated in NO-Dependent Regulation of stx2 Expression.
Bacteria detect and respond to NO by a major NO sensor, NsrR. To investigate the implication of this transcriptional repressor in the NO-dependent down-regulation of stx2 gene expression, we constructed the nsrR isogenic mutant in the strain EDL933 and the isogenic mutant transcomplemented with the plasmid pTrc99A harboring the entire nsrR gene [EDL933 ⌬nsrR(pTrc99A-nsrR)]. In the presence or absence of NOR-4, the growth of the three strains was identical (data not shown).
The expression of the gene stx2 (Fig. 5a ) and the production of Stx2 (Fig. 5b) were not significantly modulated in the ⌬nsrR and in the ⌬nsrR(pTrc99A-nsrR) strains in comparison with EDL933 under basal conditions. However, even thought to be not statistically significant, stx2 mRNA levels in the strain ⌬nsrR treated with mitomycin C were decreased in comparison with those from EDL933 or ⌬nsrR(pTrc99A-nsrR) strains stimulated with mitomycin C (Fig. 5a) . Similarly, under mitomycin C treatment, Stx2 was significantly less produced by the mutant strain when compared with both other strains. Moreover, the inhibitory effect of NO on stx2 mRNA expression (Fig. 5a ) and Stx2 production (Fig. 5b) by EDL933 was not observed in the strain EDL933 ⌬nsrR. Similar responses to mitomycin C and/or NOR-4 were observed between the transcomplemented ⌬nsrR and parental strains (Fig. 5 a and b) .
Concomitantly to stx2 mRNA expression, recA mRNA expression was increased by Ϸ7-and 2-fold for the strain EDL933 and EDL933 ⌬nsrR treated with mitomycin C in comparison with untreated cultures, respectively (data not shown).
Inhibition of stx2 Gene Expression by Human Epithelial Cell-Derived
NO. We next investigated the effect of NO produced by activated cells on stx2 expression. We used the human colonic epithelial cell line Hct-8. These cells were first treated with a cytokine mix well known to induce iNOS expression and NO production (16) . Then, cells were infected with EDL933 for 18 h in the presence or absence of an iNOS inhibitor, L-N 6 -(1-iminoethyl)lysine (NIL). When bacteria were cocultured with cytokines-activated Hct-8 cells, the spontaneous stx2 gene expression was significantly inhibited when compared with cocultures with unactivated Hct-8 cells; this decrease was reversed by using NIL in the culture of activated cells (Fig. 6a) . Concomitantly, NO was generated by activated cells but not by control cells or activated cells treated with NIL (Fig. 6a) .
In an other set of experiments, EHEC were added to control or activated Hct-8 cells for 6 h; then mitomycin C was added and bacteria were harvested 3 h after to analyze the expression of the gene stx2 (Fig. 6b) . The stx2 mRNA levels were significantly increased by 7-fold in the presence of mitomycin C in the cocultures EHEC/Hct-8 cells. This increase was significantly inhibited by Ϸ55% when bacteria were cocultured with NO producing epithelial cells. We also found that the use of NIL in EHEC/activated Hct-8 cells cocultures completely inhibited NO synthesis and restored stx2 mRNA expression (Fig. 6b) .
We confirmed our results by measurement of the cytotoxicity of the strain EDL933 in the different conditions. Without mitomycin C, the strain EDL933 induced a Ϸ15% cell mortality (SI Fig. 10 ), that was completely inhibited when Hct-8 cells were pretreated with cytokines. In the presence of mitomycin C, the cytotoxicity of the strain EDL933 on control cells and activated cells was Ϸ39% and 0%, respectively (SI Fig. 10 ). Survival was not modified when cells were treated with cytokines or mitomycin C without bacteria. Together, these results establish that in the presence of NO producing enterocytes, i.e., activated cells, Stx production is inhibited and the cytotoxicity is decreased.
Discussion
To limit the production of Stx during EHEC infection represents the ultimate strategy to avoid the development of hemolytic syndromes. In this contribution different approaches have aimed to neutralize Stx by the use of pharmacological compounds (26) , specific antibodies (27, 28) , or recombinant bacteria expressing globotriaosylceramide-3 (29) . Herein, we present NO, a critical mediator of the host mucosal innate immune response, as a potent inhibitor of Stx2 synthesis by EHEC. Our finding has a direct biological relevance, because we show that not only chemical sources of NO, but also activated human epithelial cells-derived NO, inhibits stx2 gene expression and consequently Stx2 release. We established that the spontaneous and the mitomycin C-induced activation of RecA and release of Stx2 were inhibited by NO. Previous studies identified RecA as an important contributor to spontaneous induction of phage release and Stx production (30) . Thus, we propose that NO inhibited stx2 mRNA expression in both conditions by a similar mechanism, i.e., the inhibition of RecA activation. Nevertheless, the idea that NO is associated with decreased bacterial SOS response and stx gene expression is somewhat unexpected, given that reactive nitrogen species may induce DNA damage. Thus, when used at a high concentration (35 nmol/ml/min vs. Ϸ0.5 nmol/ml/min in our experiments), NO may act as an inducer of the SOS response in E. coli (31) ; in these conditions, the recA deletion leads to a high sensitivity to NO (31) , demonstrating that the SOS response is induced and essential to fight the deleterious effects of NO. Nevertheless, ''physiological'' amounts of NO do not stimulate the SOS response in Salmonella enterica because RecA is not essential to prevent NO-dependent bacterial DNA fragmentation (32) . Moreover, several transcriptomic analysis of E. coli demonstrated that expression of the genes of the SOS response was not enhanced following exposure to NO (18) (19) (20) (21) . Additionally, we observed that stx2 mRNA expression was not modulated when bacteria were treated at the same time with mitomycin C and NOR-4. Although this result can be explained by the delay of several hours required to generate significant levels of NO, we suggest that the inhibition of the mitomycin C-induced SOS response and stx2 gene expression is linked to a long time exposure of EHEC to NO. In support of this hypothesis, we also found that Stx2 production was inhibited in EHEC treated by NO donors with elevated half-life (NOR-3 and NOR-4), but not by DEA-NONOate that releases NO within few minutes.
Investigating the mechanism by which NO suppresses Stx synthesis, we focused on the effect of one of the main bacterial NO sensor, NsrR. Our results indicate that NO signals in EDL933 strain through this sensor to mediate the NOdependent stx2 mRNA expression inhibition. Interestingly, we observed that the nsrR mutation yields to a decrease of mitomycin C-induced stx2 gene expression. This information led us to conclude that relieving NsrR DNA-binding activity, either by the effect of NO or by gene deletion, yields to the down-regulation of stx2 gene expression, and supports the likelihood that NsrR represses genes implicated in BP-933W gene regulation. The identification of the different DNA-binding site of this repressor in the strain EDL933 is therefore underway in our laboratory. Nevertheless, we also envisage that NO may protect EHEC from mitomycin C-induced BP-933W gene expression by interacting with other NO sensor and/or global regulator or by directly modulating protein activity by S-nitrosylation.
The innate immune function of NO refers to its ability to modulate inflammatory process and to kill pathogens (17) . In our experiments, EHEC killing was not induced by 200 M NO, as described for E. coli or other Gram-negative pathogenic bacteria (31) (32) (33) (34) . Further, the mitomycin C-induced EHEC killing was reversed by NO, probably because phage synthesis was inhibited by NO, thus limiting bacterial killing. Similarly, it has been shown that the use of glutathione-NO in E. coli cultures suppresses the bactericidal effect of hydrogen peroxide and hypochlorous acid (35) . Of importance, it has been described that stx genes can be horizontally transferred by the phage to commensal E. coli (36) . Consequently, the phage-susceptible intestinal microbiota can produce Stx and may participate in the pathogenesis of hemolytic syndromes (36, 37) . Thus, by inhibiting also the synthesis and the dissemination of the phage particles, NO may exert a collaterally protective effect by reducing the infection of intestinal flora by the stx-phage. Additionally, it has been described that Stx plays a function in intestinal colonization by increasing EHEC adherence to enterocytes (38); we thus suggest that NO-mediated Stx synthesis inhibition could result in less host colonization. Our study has provided insight into the host fighting against EHEC pathogenicity and HUS development. We establish that the host innate immune response represses EHEC virulence, with this particular insight that NO does not directly kill the pathogen but decreases the production of a toxin. Thus, increasing NO production in infected patients, by using NO donor or L-arginine treatment (39) , might represent an alternative strategy to limit the development of HUS. Moreover, we propose that differential NO production in infected patients could represent a marker of host susceptibility for EHEC infection.
Materials and Methods
NO Donors, NO Scavengers, and NO Detection. NO was generated by three NO donors, namely DEA-NONOate, NOR-3, and NOR-4 with half-life in PBS, pH 7.4, at 37°C of 2, 30, and 60 min, respectively (see SI Methods for chemical formula). The NO scavenger cPTIO (250 M) was also used. These compounds were purchased from Alexis Biochemicals (Lausen, Switzerland). The concentrations of the stable oxidized products of NO, NO 3 Ϫ and NO 2 Ϫ , were determined by using the Nitrite/Nitrate Assay Kit (Sigma, St. Louis, MO).
EHEC Strains and Culture Conditions. The EHEC strains EDL933 (40) and 86-24 (41) belonging to the serotype O157:H7 were used. Isolated colony of parental strains or isogenic mutants were grown overnight in LB broth containing kanamycin (50 g/ml) and/or ampicillin (50 g/ml) and subcultured (A 600 ϭ 0.02) in LB medium or used to infect the cells. Cultures were performed in the presence or absence of NO donors, NO scavenger, isopropyl ␤-D-thiogalactoside (1 mM), and/or mitomycin C (200 ng/ml). When indicated, an aliquot of each culture was harvested and centrifuged 10 min at 10,000 ϫ g; the 0.2 m-filtered supernatants were used for Stx concentration determination and phage purification, and the pellets were used for RNA extraction.
Mutagenesis. Deletion of the nsrR gene and insertion of the gene conferring resistance to kanamycin in the strain EDL933 was obtained by using the one-step PCR-based method of Datsenko and Wanner (42) . The pKOBEG plasmid expressing the red recombinases was electroporated into EDL933 strain. Strain E. coli K12 CH158 was used as a template to amplify its chromosomal copy of a gene conferring resistance to kanamycin, f lanked by nsrR-specific sequences. The 5Ј ends of the primers (MtnsrR; SI Table 1 ) contain extension sequences, which consisted of the 50 first or 50 last nucleotides of nsrR. Mutants were created by electroporating the host strains carrying pKOBEG with purified linear PCR products and then plating the organisms on selective agar. Allelic exchange was confirmed by PCR analysis and DNA sequencing. The resulting mutants have lost spontaneously the pKOBEG plasmid.
Primers consisting of the first or last nucleotides of the nsrR ORF and of the restriction sequence of the enzymes BamHI and EcoRI (CmnsrR; SI Table 1 ) were used to PCR amplify the nsrR gene from genomic DNA of EDL933. Purified PCR products were digested by the relevant enzymes and ligated into the expression vector pTrc99A, conferring resistance to ampicillin, under the control of the isopropyl ␤-D-thiogalactoside-inducible trc promoter. The resulting plasmid (pTrc99A-nsrR) was electroporated into the nsrR mutant.
To verify the mutation and the complementation of nsrR, we analyzed by semiquantitative RT-PCR the expression of the gene hmp, which is repressed by NsrR. The level of hmp mRNA was spontaneously increased by Ϸ50-fold in the ⌬nsrR strain and was not modified in the ⌬nsrR(pTrc99A-nsrR) strain in comparison with the parental strain (data not shown).
Cell Cultures and Infections. The globotriaosylceramide-3-positive human colonic epithelial cell line Hct-8 was maintained in DMEM/10% FCS/1% sodium pyruvate/10 mM Hepes/100 units/ml penicillin/100 g/ml streptomycin at 37°C under 5% CO 2 . Cells (10 6 per well) were plated on six-well plates and cultured for 7-10 days until confluence (3 ϫ 10 6 cells per well). Cells were stimulated for 24 h with a cytokine mix (each obtained from Pierce, Rockford, IL), consisting of human IFN-␥ (50 ng/ml), TNF-␣ (20 ng/ml), and IL-1␤ (5 ng/ml). Subsequently cells were washed, and a fresh complete medium devoid of antibiotics was added to the cultures, in the presence or absence of the iNOS inhibitor NIL (1 mM) and/or bacteria at a multiplicity of infection of 1.
Bacterial mRNA Analysis. To obtain standard curves for stx1, stx2, recA, and tufA genes, we first amplified genomic DNA from EDL933 strain with the primers Sstx1, Sstx2, SrecA, or StufA (SI Table 1 ) and 0.25 units of AccuTaq DNA polymerase (Invitrogen, Grand Island, NY). PCR products were purified with the Strataprep PCR Purification Kit (Stratagene, La Jolla, CA), and DNA amounts were quantified by measuring A 260 . PCR products were 10-fold serially diluted from 5 ϫ 10 8 to 50 molecules/l and amplified in the LightCycler apparatus (Roche, Mannheim, Germany) by the kit LightCycler FastStart DNA Master SYBR Green I (Roche) containing 0.5 M Estx1, Estx2, ErecA, or EtufA primers used for real-time RT-PCR (SI Table 1 ). One PCR cycle consisted of the following: 94°C for 30 s, 51°C (Estx1, Estx2, and EtufA) or 57°C (ErecA) for 30 s, and 72°C for 45 s.
Total bacterial RNA was isolated by using TRIzol, and concentration was determined by measuring the A 260 . Subsequently, 2 g of RNA from each sample was reverse-transcribed by using random primers and 5 units/l SuperScript II reverse transcriptase (Invitrogen). Serial dilutions of cDNA were amplified in the LightCycler apparatus in the same conditions as for the standard curves with the primers Estx1, Estx2, EfliC [melting temperature (T m ) ϭ 51°C], ErecA, Ehmp (T m ϭ 59°C), and EtufA (SI Table 1 ). The levels of stx1, stx2, recA, and tufA mRNA (copy number per nanogram of cDNA) were quantified by noting the fluorescence crossing point of the samples on the corresponding standard curve, and the results are presented as the ratios between the copy number of stx1, stx2, or recA mRNA and the copy number of tufA mRNA. For the other genes, results were calculated by using the comparative cycle threshold method in which the amount of target mRNA is normalized to the internal control tufA; results are expressed as relative mRNA expression compared with the strain EDL933 cultured alone.
Isolation, Observation, and Quantification of Phage Particles. Phages were purified as described by Fuchs et al. with slight modifications (30) . Bacteria culture supernatants (5 ml) were filtered by using 0.2-m filters and incubated with RNase (10 g/ml) and DNase (40 units/ml) for 30 min at 37°C. Phage particles were pelleted by ultracentrifugation overnight at 76,000 ϫ g at 4°C, resuspended in 100 l of PBS, and used for electronic microscopy and stx2 gene analysis.
Phage suspensions (10 l) were placed onto collodion-coated 300 mesh copper grids, negatively stained with 1% phosphotungstic acid for 1 min, and dried. Visualization was performed in a Hitachi (Krefeld, Germany) H-7650 transmission electron microscope at an accelerating voltage of 80 kV.
Phage suspensions (1 l) were boiled for 5 min at 95°C, and stx2 was quantified by real-time PCR by using stx2 or tufA primers and the same condition as for mRNA quantification. Moreover, classical PCR was performed with 5 l of the phage suspension, 0.5 units of AccuTaq (Sigma). One PCR cycle consisted of the following: 94°C for 30 s, 51°C for 30 s, and 68°C for 30 s. The total cycle numbers were 30. A final elongation step of 7 min at 72°C was then used. Absence of bacterial DNA in phage lysates was confirmed by the absence of tufA DNA as assayed by PCR and real-time PCR (data not shown).
Analysis of Toxin Production. Stx1 and Stx2 concentrations were measured in bacteria supernatants by ELISA, as described (43 Statistics. Student's t test was used to determine significant difference when only two treatment groups were being compared. ANOVA with the Student-Newman-Keuls test was used to analyze significant differences among multiple groups. 
